Kazemi, F., Liu, J., Parker, M., Jimenez, A. E., Ahmed, A. K., Salvatori, R., Hamrahian, A. H., Rowan, N. R., Ramanathan, M., London, N. R., Ishii, M., Rincon-Torroella, J., Gallia, G. L., & Mukherjee, D. (2025). Hospital frailty risk score predicts postoperative outcomes after endoscopic endonasal resection of non-functioning pituitary adenomas. Pituitary, 28(1). https://doi.org/10.1007/s11102-024-01496-8

Giustina, A., Uygur, M. M., Frara, S., Barkan, A., Biermasz, N. R., Chanson, P., Freda, P., Gadelha, M., Haberbosch, L., Kaiser, U. B., Lamberts, S., Laws, E., Nachtigall, L. B., Popovic, V., Schilbach, K., Lely, A. J. van der, Wass, J. A. H., Melmed, S., & Casanueva, F. F. (2025). Medical management pathways for Cushing’s disease in pituitary tumors centers of excellence (PTCOEs). Pituitary, 28(1). https://doi.org/10.1007/s11102-024-01485-x

Giustina, A., Uygur, M. M., Frara, S., Barkan, A., Biermasz, N. R., Chanson, P., Freda, P., Gadelha, M., Haberbosch, L., Kaiser, U. B., Lamberts, S., Laws, E., Nachtigall, L. B., Popovic, V., Reincke, M., van der Lely, A. J., Wass, J. A. H., Melmed, S., & Casanueva, F. F. (2024). Standards of care for medical management of acromegaly in pituitary tumor centers of excellence (PTCOE). Pituitary, 27(4), 381–388. https://doi.org/10.1007/s11102-024-01397-w

Freda, P. U. (2024). Impact of medical therapy for hormone-secreting Pituitary tumors on bone. Pituitary. https://doi.org/10.1007/s11102-024-01421-z

Page-Wilson, G., Oak, B., Silber, A., Meyer, J., O’Hara, M., & Geer, E. B. (2024). A medical chart audit to assess endocrinologist perceptions of the burden of endogenous Cushing’s syndrome. Pituitary, 27(2), 129–140. https://doi.org/10.1007/s11102-023-01371-y

Giustina, A., Uygur, M. M., Frara, S., Barkan, A., Biermasz, N. R., Chanson, P., Freda, P., Gadelha, M., Kaiser, U. B., Lamberts, S., Laws, E., Nachtigall, L. B., Popovic, V., Reincke, M., Strasburger, C., van der Lely, A. J., Wass, J. A. H., Melmed, S., & Casanueva, F. F. (2023). Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary, 26(5), 583–596. https://doi.org/10.1007/s11102-023-01345-0

Lin, A. L., Geer, E. B., Lala, N., Page-Wilson, G., Magge, R., Young, R. J., & Tabar, V. (2023). The treatment of aggressive prolactinomas with everolimus. Pituitary, 26(4), 474–481. https://doi.org/10.1007/s11102-023-01340-5